Princeton Global Asset Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-70
| Closed | -$5K | – | 556 |
|
|
2022
Q3 | $5K | Hold |
70
| – | – | ﹤0.01% | 448 |
|
|
2022
Q2 | $4K | Hold |
70
| – | – | ﹤0.01% | 482 |
|
|
2022
Q1 | $4K | Sell |
70
-240
| -77% | -$13.7K | ﹤0.01% | 512 |
|
|
2021
Q4 | $23K | Sell |
310
-3,899
| -93% | -$289K | 0.01% | 323 |
|
|
2021
Q3 | $471K | Sell |
4,209
-350
| -8% | -$39.2K | 0.14% | 127 |
|
|
2021
Q2 | $738K | Buy |
4,559
+259
| +6% | +$41.9K | 0.22% | 103 |
|
|
2021
Q1 | $524K | Buy |
+4,300
| New | +$524K | 0.17% | 117 |
|